GlaxoSmithKline: all 4,196 studies
Page 5 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC)CompletedNCT03739710Phase 2Results posted
- A Study to Investigate Food Occlusion Efficacy of a Denture Adhesive in Denture WearersCompletedNCT03709810Phase 4Results posted
- Pilot Immunotherapy Study With Letetresgene Autoleucel (Lete-cel, GSK3377794)T-cells in New York Esophageal Squamous Cell Carcinoma-1 (NY-ESO-1)/ LAGE-1a-positive Advanced Non-small Cell Lung Cancer (NSCLC) Either Alone or in Combination With PembrolizumabTerminatedNCT03709706Phase 1/2Results posted
- GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid TumorsCompletedNCT03693612Phase 1/2Results posted
- Enhanced Safety Surveillance of GlaxoSmithKline's (GSK's) Quadrivalent Seasonal Influenza Vaccines During the 2018/19 Influenza SeasonCompletedNCT03688620Phase 4Results posted
- Safety and Efficacy of Dolutegravir/Lamivudine (DTG/3TC) in Therapy-naive Human Immunodeficiency Virus-1 (HIV-1) Infected AdolescentsCompletedNCT03682848Phase 3Results posted
- First-time-in-human (FTIH) Study of GSK3145095 Alone and in Combination With Other Anticancer Agents in Adults With Advanced Solid TumorsTerminatedNCT03681951Phase 2Results posted
- Dose Escalation and Expansion Study of FLX475 Monotherapy and in Combination With PembrolizumabCompletedNCT03674567Phase 1/2Results posted
- A Study to Evaluate Different Dose Levels of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3888550A), Based on the Vaccine Safety and the Antibodies (Body Defences) Produced Following Vaccine Administration, When Given to Healthy Non-pregnant WomenCompletedNCT03674177Phase 1Results posted
- A Post-marketing Surveillance Study to Assess the Safety of Cervarix (GlaxoSmithKline [GSK] Biologicals' Human Papillomavirus [HPV] -16/18 Vaccine), When Administered According to the Approved Prescribing Information (PI) in KoreaCompletedNCT03671369Results posted
- First Time in Humans (FTIH) Study of GSK3368715 in Participants With Solid Tumors and Diffuse Large B-cell Lymphoma (DLBCL)TerminatedNCT03666988Phase 1Results posted
- A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adults 18 to 40 Years of AgeCompletedNCT03652610Phase 2Results posted
- A Study to Investigate the Pharmacokinetics (PK) of Modified Release (MR) Prototype Coated Tablet Formulations of GSK2982772CompletedNCT03649412Phase 1Results posted
- A Clinical Study to Investigate the Dermal and Ocular Tolerance of a Developmental Cosmetic Facial Serum Formulation in Healthy Females With Sensitive SkinCompletedNCT03640832Not applicableResults posted
- Phase 2b, Open-label, Multicenter, Rollover Study to Assess Antiviral Activity and Safety of Long-acting (LA) Cabotegravir (CAB) Plus LA Rilpivirine (RPV), Administered Every 2 Months (Q2M), in Human Immunodeficiency Virus (HIV)-Positive Participants From the LATTE StudyCompletedNCT03639311Phase 2Results posted
- Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSVCompletedNCT03636906Phase 1/2Results posted
- Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 StudyCompletedNCT03629886Phase 4Results posted
- First Time in Human (FTIH) Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Single and Repeat Doses of GSK3439171A in Healthy Subjects and to Assess Food EffectCompletedNCT03627494Phase 1Results posted
- Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy InfantsCompletedNCT03621670Phase 3Results posted
- Twinrix Pregnancy RegistryCompletedNCT03619590Results posted
- Study to Investigate the Safety and Clinical Activity of GSK3326595 and Other Agents to Treat Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)TerminatedNCT03614728Phase 1/2Results posted
- A Study of Outcomes and Events of Interest in Pregnant Women, Neonates and Infants and of RSV SurveillanceCompletedNCT03614676Not applicableResults posted
- A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian CancerActive, not recruitingNCT03602859Phase 3Results posted
- Phase I Study of GSK2982772 in Japanese Healthy Male ParticipantsCompletedNCT03590613Phase 1Results posted
- Effect of Two Toothpastes on Bacteria in SalivaCompletedNCT03587428Not applicableResults posted
- Study to Assess Potential Immune Interference When GlaxoSmithKline (GSK) Biologicals' MenABCWY Vaccine is Administered to Healthy Subjects Aged 10-25 YearsCompletedNCT03587207Phase 2Results posted
- A Study to Compare the Relative Bioavailability of Two Different Formulations of GSK3640254CompletedNCT03575962Phase 1Results posted
- A Study to Evaluate the Efficacy and Safety of Novel Treatment Combinations in Participants With Ovarian CancerCompletedNCT03574779Phase 2Results posted
- Pharmacokinetic Study of Oral Gepotidacin (GSK2140944) in Subjects With Uncomplicated Urinary Tract Infection (Acute Cystitis)CompletedNCT03568942Phase 2Results posted
- A Study to Assess Frailty of Subjects During ZOSTER-006 and ZOSTER-022CompletedNCT03563183Results posted
- A Safety and Efficacy Study of Mepolizumab in Subjects With Severe AsthmaCompletedNCT03562195Phase 3Results posted
- Pharmacokinetics (PK) Study of Gepotidacin (GSK2140944) in Adult Subjects With Varying Degrees of Hepatic Impairment and in Matched Control Subjects With Normal Hepatic FunctionCompletedNCT03562117Phase 1Results posted
- An Early Bactericidal Activity, Safety and Tolerability of GSK3036656 in Subjects With Drug-sensitive Pulmonary TuberculosisCompletedNCT03557281Phase 2Results posted
- NUCALA® Special Drug Use Investigation (EGPA, Long-term)CompletedNCT03557060Results posted
- Bioequivalence Study Between Levocetirizine Oral Disintegrating Tablet (ODT) and Levocetirizine Immediate Release Tablet (IRT)CompletedNCT03555890Phase 1Results posted
- A Pivotal Study to Assess the Effectiveness of Nasal Dilator (Breathe Right Nasal Strips)CompletedNCT03549130Phase 2Results posted
- A Pivotal Subjective Sleep Study of a Nasal Dilator (Breathe Right Tan)CompletedNCT03549117Phase 2Results posted
- To Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-drug Conjugate, GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or in Combination With Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)CompletedNCT03544281Phase 1/2Results posted
- Chronic Obstructive Pulmonary Disease (COPD) Dual Therapy Burden of IllnessCompletedNCT03543176Results posted
- To Assess the Bioequivalence of the 4mg Prototype Mini Nicotine Lozenge to the Reference Product (Nicorette) in Healthy SmokersCompletedNCT03543137Phase 1Results posted
- A Bioequivalence Study of Two Nicotine Lozenges in Fasting Conditions in Healthy SmokersCompletedNCT03541044Phase 1Results posted
- A Study to Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With Shigella Sonnei in Healthy AdultsCompletedNCT03527173Phase 2Results posted
- A Study to Investigate the Efficacy and Safety of Two Doses of GSK2857916 in Participants With Multiple Myeloma Who Have Failed Prior Treatment With an Anti-CD38 AntibodyCompletedNCT03525678Phase 2Results posted
- Dolutegravir/Rilpivirine, Antiretroviral Efficacy Study Using Real-world Data in Subjects With Human Immunodeficiency Virus (HIV)-1CompletedNCT03518060Results posted
- Effects of GSK2798745 on Alveolar Barrier Disruption in a Segmental Lipopolysaccharide (LPS) Challenge ModelTerminatedNCT03511105Phase 1Results posted
- A Study to Characterize Diclofenac's Plasma and Knee Exposure After Application of Diclofenac Gel to the Knee of Subjects With Osteoarthritis That Have a Scheduled ArthroplastyCompletedNCT03497039Phase 1Results posted
- A Clinical Study to Evaluate the Efficacy of Three Dry Mouth Relief Products Versus WaterCompletedNCT03494985Not applicableResults posted
- A Sourcing Study to Collect Human Blood Samples From Healthy AdultsCompletedNCT03493919Phase 4Results posted
- Daprodustat Bioequivalence and Food Effect StudyCompletedNCT03493386Phase 1Results posted
- A Safety, Tolerability, Pharmacokinetics (PK) and Target Engagement (TE) Study of GSK3858279 in Healthy Participants and Evaluation of the Efficacy of Repeat Doses in Participants With Osteoarthritis (OA)CompletedNCT03485365Phase 1Results posted
- A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03478696Phase 4Results posted
- A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03478683Phase 4Results posted
- An Open-label Study to Evaluate Correct Use and Ease of Use of the ELLIPTA DPI in Pediatric Subjects With AsthmaCompletedNCT03478657Phase 4Results posted
- Oral and Dermal Tolerability Clinical Study of an Experimental Denture WipeCompletedNCT03478644Not applicableResults posted
- A Comparative Study Between Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy Versus Tiotropium Monotherapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03474081Phase 4Results posted
- INTREPID: Investigation of TRELEGY Effectiveness: Usual Practice DesignCompletedNCT03467425Phase 4Results posted
- The Safety of Boostrix Following Routine Immunization of Pregnant WomenCompletedNCT03463577Results posted
- GSK1325756 Relative Bioavailability Study in Healthy Elderly SubjectsCompletedNCT03457727Phase 1Results posted
- Anemia Studies in CKD: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat- Iron (ASCEND: Fe)CompletedNCT03457701Phase 2Results posted
- Study of a Combination of GSK1795091 and Immunotherapies in Subjects With Advanced Solid TumorsCompletedNCT03447314Phase 1Results posted
- Anemia Study in Chronic Kidney Disease (CKD) : Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat -Forearm Blood Flow (ASCEND-FBF)TerminatedNCT03446612Phase 2Results posted
- Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)CompletedNCT03446573Phase 3Results posted
- A Study to Test if a Third Dose of the Vaccine is Safe in Current and Former Smokers Aged 40 to 80 Years Old and to Gather Information on the Immune Response Following the Third Dose of the VaccineCompletedNCT03443427Phase 2Results posted
- To Assess the Relative Bioavailability (BA) of TRIUMEQ® and Dolutegravir and Lamivudine (DTG/3TC) Pediatric Dispersible Tablet Formulations in Healthy VolunteersCompletedNCT03441984Phase 1Results posted
- Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and OlderCompletedNCT03439657Phase 3Results posted
- A Post Marketing Surveillance (PMS) Study to Monitor the Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Female Chinese SubjectsCompletedNCT03438006Results posted
- A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of AgeCompletedNCT03433482Phase 2Results posted
- First-time-in-Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single (in Both Fed and Fasted States) or Repeat Doses of GSK3358699TerminatedNCT03426995Phase 1Results posted
- A Safety, Tolerability, Acceptability, and Pharmacokinetic (PK) Study of Cabotegravir (CAB) in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Chinese MenCompletedNCT03422172Phase 1Results posted
- Biodistribution of 89Zirconium-labelled GSK2398852 Using PET ImagingTerminatedNCT03417830Phase 1Results posted
- To Investigate the Gastrointestinal Behaviour of Two Triple Combination Products in Healthy Male VolunteersCompletedNCT03415243Phase 1Results posted
- Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)CompletedNCT03409107Phase 3Results posted
- Bioequivalence Study Between SKF101804 Cefixime 200 Milligram (mg)/5 Milliliter (mL) Suspension Versus Cefixime 200 mg/5 mL Suspension Reference Product in Healthy Adult Subjects Under Fasting ConditionsCompletedNCT03408392Phase 1Results posted
- Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-Three-times Weekly Dosing in Dialysis (ASCEND-TD)CompletedNCT03400033Phase 3Results posted
- A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics (PK) of NemiralisibCompletedNCT03398421Phase 1Results posted
- Repeat Dose Study of GSK3772847 in Participants With Moderate to Severe Asthma With Allergic Fungal Airway Disease (AFAD)TerminatedNCT03393806Phase 2Results posted
- A Clinical Study to Evaluate the Effect of the Connected Inhaler System (CIS) on Adherence to Maintenance Therapy in Poorly Controlled Asthmatic SubjectsCompletedNCT03380429Phase 4Results posted
- A Study to Assess the Effectiveness and Side Effects of GSK2798745 in Participants With Chronic CoughTerminatedNCT03372603Phase 1/2Results posted
- BENLYSTA® Special Drug Use InvestigationCompletedNCT03370263Results posted
- Long-term Immunogenicity of the HIV gp120-NefTat/AS01B Vaccine (GSK SB732461)CompletedNCT03368053Phase 1Results posted
- Pharmacokinetic and Safety Study of Niraparib With Normal or Moderate Hepatic Impairment PatientsCompletedNCT03359850Phase 1Results posted
- Study to Evaluate the Safety and Efficacy of 13 Weeks of the Selective Androgen Receptor Modulator (SARM) GSK2881078 in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT03359473Phase 2Results posted
- GSK2983559 First Time in Human StudyTerminatedNCT03358407Phase 1Results posted
- Sensor and Electronic Health Records (EHR) Integration Pilot StudyCompletedNCT03357341Results posted
- A Follow-up Extension Study to Evaluate the Persistence of Immune Response to GSK Biologicals' HPV Vaccine in Healthy Chinese Female Subjects Who Received Three Doses of the Vaccine in the HPV-058 StudyCompletedNCT03355820Phase 3Results posted
- Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)TerminatedNCT03345407Phase 2Results posted
- A Study to Investigate a Method to Measure Food Occlusion by Denture Adhesives in Denture WearersCompletedNCT03345108Not applicableResults posted
- Study Evaluating the Antitumor Activity and Safety of Niraparib as Neoadjuvant Treatment in Participants With Breast CancerCompletedNCT03329937Phase 1Results posted
- Bioequivalence Study of Paroxetine Immediate Release (IR) Tablets Manufactured in GlaxoSmithKline Tianjin (GSKT) and Mississauga Sites in Healthy Chinese SubjectsCompletedNCT03329573Phase 1Results posted
- Crossover Study to Assess the Relative Bioavailability and Bioequivalence of Niraparib Tablet Compared to Niraparib CapsuleCompletedNCT03329001Phase 1Results posted
- A Study of Niraparib Combined With Bevacizumab Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based ChemotherapyCompletedNCT03326193Phase 2Results posted
- Pediatric Ease of Use ELLIPTA ItemsCompletedNCT03315572Results posted
- Absorption & Elimination of Radiolabelled GSK2269557CompletedNCT03315559Phase 1Results posted
- A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVECompletedNCT03312907Phase 3Results posted
- Evaluation of Immunogenicity, Safety and Reactogenicity of GSK Biologicals' Boostrix Vaccine Administered as a Booster Dose in Healthy Russian SubjectsCompletedNCT03311659Phase 3Results posted
- A Clinical Study to Evaluate a Stannous Fluoride Toothpaste for the Relief of Dentinal HypersensitivityCompletedNCT03310268Not applicableResults posted
- Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer ParticipantsCompletedNCT03308942Phase 2Results posted
- Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042CompletedNCT03307785Phase 1Results posted
- Lipopolysaccharide (LPS) or Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Challenge Study on Healthy SubjectsCompletedNCT03306589Phase 1Results posted
- A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622CompletedNCT03306043Phase 3Results posted